Literature DB >> 11384847

Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.

G Meier1, J Apelt, U Reichert, S Grassmann, X Ligneau, S Elz, F Leurquin, C R Ganellin, J C Schwartz, W Schunack, H Stark.   

Abstract

The reference compounds for histamine H(3)-receptor antagonists carry as a common feature an imidazole moiety substituted in the 4-position. Very recently novel ligands lacking an imidazole ring have been described possessing a N-containing non-aromatic heterocycle instead. In this study we investigated whether imidazole replacement, favourably by a piperidine moiety, is generally applicable to different structural classes of reference compounds, e.g., thioperamide, carboperamide, clobenpropit, FUB 181, ciproxifan, etc. While replacement led to a loss of affinity for many of the compounds, it was successfully applied to some ether derivatives. The piperidine analogues of FUB 181 and ciproxifan, 3-(4-chlorophenyl)propyl 3-piperidinopropyl ether hydrogen oxalate (6) and cyclopropyl 4-(3-piperidinopropyloxy)phenyl methanone hydrogen maleate (7), almost maintained in vitro affinities, pK(i) values of 7.8 and 8.4, respectively, and showed high potency in vivo after p.o. administration (ED(50) values of 1.6 and 0.18 mg/kg, respectively).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384847     DOI: 10.1016/s0928-0987(01)00106-3

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  13 in total

1.  Processing of NMR and MS metabolomics data using chemometrics methods: a global tool for fungi biotransformation reactions monitoring.

Authors:  Cécile Palaric; Serge Pilard; Jean-Xavier Fontaine; Julien Boccard; David Mathiron; Sébastien Rigaud; Dominique Cailleu; François Mesnard; Yoann Gut; Tristan Renaud; Alain Petit; Jean-Yves Beaumal; Roland Molinié
Journal:  Metabolomics       Date:  2019-07-25       Impact factor: 4.290

2.  Overdose of the histamine H₃ inverse agonist pitolisant increases thermal pain thresholds.

Authors:  Dong Dong Zhang; Marco Sisignano; Claus Dieter Schuh; Kerstin Sander; Holger Stark; Klaus Scholich
Journal:  Inflamm Res       Date:  2012-07-21       Impact factor: 4.575

Review 3.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

4.  Generation of a homology model of the human histamine H(3) receptor for ligand docking and pharmacophore-based screening.

Authors:  Birgit Schlegel; Christian Laggner; Rene Meier; Thierry Langer; David Schnell; Roland Seifert; Holger Stark; Hans-Dieter Höltje; Wolfgang Sippl
Journal:  J Comput Aided Mol Des       Date:  2007-08-01       Impact factor: 3.686

5.  Non-imidazole histamine H3 ligands: part V. synthesis and preliminary pharmacological investigation of 1-[2-thiazol-4-yl- and 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.

Authors:  Roman Guryn; Marek Staszewski; Krzysztof Walczyński
Journal:  Med Chem Res       Date:  2012-11-29       Impact factor: 1.965

6.  Novel chalcone-based fluorescent human histamine h(3) receptor ligands as pharmacological tools.

Authors:  Miriam Tomasch; J Stephan Schwed; Lilia Weizel; Holger Stark
Journal:  Front Syst Neurosci       Date:  2012-03-26

7.  Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands.

Authors:  Bassem Sadek; Annemarie Schreeb; Johannes Stephan Schwed; Lilia Weizel; Holger Stark
Journal:  Drug Des Devel Ther       Date:  2014-09-19       Impact factor: 4.162

8.  Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists.

Authors:  Bassem Sadek; Ali Saad; Johannes Stephan Schwed; Lilia Weizel; Miriam Walter; Holger Stark
Journal:  Drug Des Devel Ther       Date:  2016-11-07       Impact factor: 4.162

9.  Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.

Authors:  Bassem Sadek; Ali Saad; Gniewomir Latacz; Kamil Kuder; Agnieszka Olejarz; Tadeusz Karcz; Holger Stark; Katarzyna Kieć-Kononowicz
Journal:  Drug Des Devel Ther       Date:  2016-11-25       Impact factor: 4.162

10.  The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats.

Authors:  Nermin Eissa; Nadia Khan; Shreesh K Ojha; Dorota Łazewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-02-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.